Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that it expects the Swiss SIX exchange to ...
The previous forecast of bet-at-home.com AG (hereinafter also referred to as the "BaH") assumed that bet-at-home.com AG Group will achieve in the financial year 2024 a gross betting and gaming revenue ...
Merger Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger 04-Nov-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is ...
Takeover/Takeover LEG Immobilien SE: Acquisition of Brack Capital Properties N.V. through the conclusion of a share purchase agreement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback